Back to Journals » OncoTargets and Therapy » Volume 13

Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway

Total article views   HTML views PDF downloads Totals
5,752 Dovepress* 5,083+ 735 5,818
PubMed Central* 669 158 827
Totals 5,752 893 6,645
*Since 2 October 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar